Pathyaപഥ്യം
← New record

IndiPGx-Pop p080

Lab reportcohort · india-sim

10/30/2026, 1:53:46 PM · PharmCAT 3.4.0 · Research record, not medical advice

2
Genes standardised
2
Calls quoted
0
Coverage gaps
0
Identifiers removed
22.9s
Upload to record
  1. Muse Sparkread 2 gene calls10.1s
  2. PharmCATstandardised 2 genes12.8s
  3. Rules0 coverage gaps

CallsMuse Spark each call quoted from the source, then standardised by PharmCAT

Synthetic Genomics Lab (Kochi) · 3 Oct 2026 · open original photo

Uploaded lab report photo
GeneAs printedStandardisedPhenotype term
NUDT15“NUDT15 rs116855232 (*3) *3/*1 Intermediate metabolizer”*3/*1Intermediate Metabolizer
TPMT“TPMT *2, *3A, *3B, *3C *1/*1 Normal metabolizer”*1/*1Normal Metabolizer

Method as printed: Method: targeted genotyping by real-time PCR. Only the listed variants are assayed; variants outside this panel cannot be excluded.

Coveragedeterministic rules · which India-relevant variants this panel named

NUDT15*3named on the report

Main NUDT15 risk allele, ~7-11% in Indians (PMID 29470173)

TPMT*3Cnamed on the report

Most common TPMT variant in South Asians

A variant the panel did not name is left out of cohort statistics for that variant, rather than counted as absent. Reader notes: Only the listed variants are assayed; variants outside this panel cannot be excluded. TPMT *1/*1 reflects only tested variants *2, *3A, *3B, *3C; untested variants cannot be excluded.

Exportde-identified · the same record in three formats

Curator review

A curator checks each call against the source document before the record counts in a cohort, and Muse Spark web search finds published Indian frequency data for each variant. Both are written to the audit log. Reviewing is the one action that needs a curator code, because it is a claim that a person checked the page.

Sign in as a curator
Research tool, not medical advice. Pathya reads and standardises pharmacogenomic results; it makes no dose, drug or test recommendation. Audit log: data/cases/20fa34a01803/audit.log.